Rab Faruqi

Statistics

Publications

Citations

686

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

National Allergy Asthma Bronchitis Institute

Seoul National University Hospital

Khon Kaen University

National University of Singapore

Rab Faruqi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pulmonology, and chronic obstructive pulmonary disease.

Publications per year

2009–2016

Publications

Insights, attitudes and perceptions about asthma and its treatment: Findings from a multinational survey of patients from 8 <scp>A</scp>sia‐<scp>P</scp>acific countries and <scp>H</scp>ong <scp>K</scp>ong

Philip J. Thompson, Sundeep Salvi, Jiangtao Lin et al. · Respirology · 2013 · 101 citations

Medicine, Internal Medicine, Allergy +10

Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

Kwang Ha Yoo, Hae-Ryun Ahn, Jae-Kyoung Park et al. · Allergy Asthma and Immunology Research · 2016 · 93 citations · Full text

Medicine, Internal Medicine, Otolaryngology +17

Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic Response

Yoav Lurie, N. G. Zakharova, Andrzej Horban et al. · Hepatology · 2010 · 72 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Level of asthma control and health care utilization in Asia-Pacific countries

Laura S. Gold, Phillip Thompson, Sundeep Salvi et al. · Respiratory Medicine · 2013 · 65 citations · Full text

Public Health, Chronic Disease Control, Preventive Medicine +11

Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C

Michael P. Manns, Stefan Zeuzem, Ajit Sood et al. · Journal of Hepatology · 2011 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +14

1–5 of 13